Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials

ABSTRACT Neoadjuvant immunotherapy‐based combination holds promises in reducing surgical risk and improving survival for renal cell carcinoma (RCC) with venous tumor thrombus (VTT). However, its role in RCC–VTT has been less explored. To evaluate the efficacy and safety of neoadjuvant toripalimab pl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Cheng Peng, Zhuolong Wu, Yaohui Wang, Qiyang Liang, Dongxing Wang, Houming Zhao, Jinhang Li, Xiuzheng Yue, Yibo Zhang, Jialong Song, Changwei Shi, Haiyi Wang, Guoqiang Yang, Baojun Wang, Qingbo Huang, Xu Zhang, Xin Ma, Jiwei Huang, Liangyou Gu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
coleção:	MedComm
Assuntos:	drug resistance neoadjuvant immunotherapy‐based combination renal cell carcinoma thrombectomy venous tumor thrombus
Acesso em linha:	https://doi.org/10.1002/mco2.70720
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!